Immix BiopharmaIMMX
13F holders, Q4 2024 (December 31)23holders −2
4new positions
7sold out
$2.20avg. 13F price*
At the end of Q4 2024, 23 institutions reported holding Immix Biopharma Inc. (IMMX) in their 13F filings, down 2 from Q3 2024. 4 opened new positions and 7 sold out. The largest holders were Bleichroeder LP ($1.9M), Cable Car Capital, LP ($1.8M) and Vanguard Group Inc. ($1.5M).
- Company
- Immix Biopharma Inc.
- CUSIP
- 45258H106
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $102K |
| Exits | 7 | $1.8M |
All 13F filers, Q3 2024 → Q4 2024: 61,206 shares bought and 1,302,402 shares sold, net −1,241,196 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 23 holders
| Bleichroeder LP | 0.47% | No change | 850,000 | $1.9M |
| Cable Car Capital, LP | 0.13% | No change | 796,100 | $1.8M |
| Vanguard Group Inc. | 0.00% | No change | 698,537 | $1.5M |
| Geode Capital Management, LLC | 0.00% | No change | 150,082 | $330K |
| Morgan Stanley | 0.00% | Add +8.0% | 91,051 | $200K |
| State Street Corp. | 0.00% | No change | 42,960 | $95K |
| Northern Trust Corp. | 0.00% | No change | 38,914 | $86K |
| Tocqueville Asset Management L.P. | 0.00% | Reduce -11.6% | 38,300 | $84K |
| Private Advisor Group, LLC | 0.00% | Reduce -9.0% | 31,225 | $69K |
| FNY Investment Advisers, LLC | 0.03% | New | 28,750 | $63K |
| Commonwealth Equity Services, LLC | 0.00% | Reduce -0.8% | 25,860 | $57K |
| Jane Street Group, LLC | 0.00% | New | 17,523 | $39K |
| SBI Securities Co., Ltd. | 0.00% | — | 17,500 | $39K |
| UBS Group AG | 0.00% | Add +131.2% | 14,208 | $31K |
| BlackRock, Inc. | 0.00% | Add +0.5% | 14,076 | $31K |
| Focus Partners Wealth | 0.00% | No change | 11,900 | $26K |
| Royal Bank of Canada | 0.00% | Reduce -97.6% | 2,000 | $4K |
| Tortoise Investment Management, LLC | 0.00% | No change | 1,300 | $3K |
| Wells Fargo & Company | 0.00% | No change | 330 | $726 |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -94.2% | 181 | $398 |
| Bank of America Corp. | 0.00% | Reduce -0.9% | 114 | $251 |
| JPMorgan Chase & Co. | 0.00% | New | 38 | $84 |
| Simplex Trading, LLC | 0.00% | New | 22 | $0 |
"% of holder's portfolio" is IMMX's weight in each manager's 13F, not the share of Immix Biopharma Inc. the manager owns.